
Dibiglim 1mg Tablet
Marketer
Novartis India Ltd
Salt Composition
Glimepiride (1mg)
Overview Dibiglim 1mg Tablet
Glyburide 1mg tablets, a sulfonylurea-class medication, manage type 2 diabetes in adults by regulating blood glucose, thus mitigating risks like vision impairment and kidney complications. This medication can be prescribed alone or in conjunction with other treatments. Administer it immediately before or with your first daily meal, consistently at the same time for optimal efficacy. Dosage is personalized by your physician and may adjust based on blood sugar monitoring. Continuous use of Glyburide 1mg tablets is vital, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose levels and subsequent risks including nephropathy, blindness, neuropathy, and limb loss. This medication is one component of a comprehensive diabetes management plan, complementing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headaches, and tremors; nausea; headache; weakness; and vertigo. Maintain regular mealtimes and carry readily-available glucose sources (e.g., fruit juice, sugary sweets) to counter hypoglycemia. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Weight gain is a possible side effect. Glyburide 1mg tablets are contraindicated for type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior to starting this medication, disclose any history of heart disease, thyroid disorders, or hormonal imbalances to your physician. Pregnant or lactating individuals must consult their physician before initiating treatment. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function tests) will be necessary.
Uses of Dibiglim 1mg Tablet
Managing type 2 diabetes
Major Benefits of Dibiglim 1mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Dibiglim 1mg Tablet should be administered with a meal.
Common Side effects of Dibiglim 1mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Dizziness
- Weakness
How to use Dibiglim 1mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the entire tablet without chewing, crushing, or fracturing it. The Dibiglim 1mg Tablet should be administered with a meal.
How Dibiglim 1mg Tablet works:
One milligram Dibiglim tablets are used to treat diabetes. Their mechanism of action involves stimulating pancreatic insulin secretion, thereby reducing blood sugar levels.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Dibiglim 1mg Tablet is strongly discouraged due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Dibiglim 1mg Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the unborn. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Lactation and the use of Dibiglim 1mg Tablets are likely incompatible. Available data indicates potential drug transfer via breastmilk, posing a risk to the infant. Close observation of the nursing infant's blood sugar levels is recommended while the mother takes Dibiglim 1mg Tablets.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Dibiglim 1mg tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. Dibiglim 1mg tablets are contraindicated in patients with severe kidney disease due to the risk of severe hypoglycemia, which may resolve gradually.
LiverCAUTION
Patients with liver impairment should use Dibiglim 1mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Dibiglim 1mg tablets are contraindicated in patients with severe hepatic dysfunction due to the risk of significant hypoglycemia, which may resolve only after an extended period.
What if you forget to take Dibiglim 1mg Tablet :
Omit the forgotten Dibiglim 1mg Tablet dose; continue with your regular dosing schedule.
Facts to Know About Dibiglim 1mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Advanced Sulfonylurea |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
